Investments
68Portfolio Exits
12Funds
3About Ysios Capital Partners
Ysios Capital Partners is an independent venture capital firm. Ysios Capital Partners has its main office in Barcelona and the company invests in businesses that focus on human healthcare innovations (Life Science & Healthcare), primarily in Spain.
Want to inform investors similar to Ysios Capital Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Ysios Capital Partners News
Jun 16, 2020
Send to Asabys Partners, alongside Alta Life Sciences, BPI France, Fund+ and Ysios Capital Partners, have invested in a €30m series-A round for drug development company Ona Therapeutics. To continue reading... Customer services If you encounter issues logging in with your credentials, please contact our customer services team and we will endeavour to assist as quickly as possible Get access to Unquote Unquote delivers the latest news, research and analysis on the European venture capital and private equity markets. Request a free demonstration or subscribe now. Please click on one of the buttons below.
Ysios Capital Partners Investments
68 Investments
Ysios Capital Partners has made 68 investments. Their latest investment was in Tagworks Pharmaceuticals as part of their Series A on June 6, 2023.
Ysios Capital Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/22/2023 | Series A | Tagworks Pharmaceuticals | $65M | Yes | 5 | |
5/25/2023 | Series B - II | VarmX | $32.16M | No | 2 | |
4/4/2023 | Series A - II | ADCendo | $33.87M | No | 6 | |
9/14/2022 | Series B | |||||
6/8/2022 | Series B |
Date | 6/22/2023 | 5/25/2023 | 4/4/2023 | 9/14/2022 | 6/8/2022 |
|---|---|---|---|---|---|
Round | Series A | Series B - II | Series A - II | Series B | Series B |
Company | Tagworks Pharmaceuticals | VarmX | ADCendo | ||
Amount | $65M | $32.16M | $33.87M | ||
New? | Yes | No | No | ||
Co-Investors | |||||
Sources | 5 | 2 | 6 |
Ysios Capital Partners Portfolio Exits
12 Portfolio Exits
Ysios Capital Partners has 12 portfolio exits. Their latest portfolio exit was Mineralys Therapeutics on February 10, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/10/2023 | IPO | Public | 5 | ||
11/22/2021 | Acquired | 6 | |||
10/29/2021 | IPO | Public | 10 | ||
Date | 2/10/2023 | 11/22/2021 | 10/29/2021 | ||
|---|---|---|---|---|---|
Exit | IPO | Acquired | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | |||
Sources | 5 | 6 | 10 |
Ysios Capital Partners Fund History
3 Fund Histories
Ysios Capital Partners has 3 funds, including Ysios BioFund III.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
5/26/2021 | Ysios BioFund III | $264.35M | 3 | ||
10/18/2016 | Ysios BioFund II | ||||
12/31/2008 | Ysios BioFund I |
Closing Date | 5/26/2021 | 10/18/2016 | 12/31/2008 |
|---|---|---|---|
Fund | Ysios BioFund III | Ysios BioFund II | Ysios BioFund I |
Fund Type | |||
Status | |||
Amount | $264.35M | ||
Sources | 3 |
Ysios Capital Partners Team
4 Team Members
Ysios Capital Partners has 4 team members, including current Founder, Managing Partner, Joël Jean-Mairet.
Name | Work History | Title | Status |
|---|---|---|---|
Joël Jean-Mairet | Founder, Managing Partner | Current | |
Name | Joël Jean-Mairet | |||
|---|---|---|---|---|
Work History | ||||
Title | Founder, Managing Partner | |||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
